MUFG Capital joins Zurich-based Numab Therapeutics' $22.6m Series B

MUFG Capital joins Zurich-based Numab Therapeutics' $22.6m Series B

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter